From: Internal mammary lymph node recurrence: rare but characteristic metastasis site in breast cancer
Factors | N | Univariate analysis | Multivariate analysis | |||
---|---|---|---|---|---|---|
 |  | Median (m) | p-value | HR | 95%CI | p-value |
As first site of metastasis | Â | Â | 0.407 | NS | ||
   Yes | 121 | 34 |  |  |  |  |
   No | 12 | 64 |  |  |  |  |
Size of IMLN | Â | Â | 0.984 | NS | ||
   ≤4 cm | 116 | 51 |  |  |  |  |
   >4 cm | 17 | 38 |  |  |  |  |
DFI of IMLN recurrence | Â | Â | 0.001* | 1.4 | 0.7- 2.9 | 0.342 |
   <2 y | 44 | 31 |  |  |  |  |
   ≥2 y | 89 | 63 |  |  |  |  |
Concurrent metastasis | Â | Â | 0.024* | 0.7 | 0.4- 0.9 | 0.031* |
   No and local | 73 | 61 |  |  |  |  |
   Visceral or bone | 60 | 32 |  |  |  |  |
Endocrine therpay | Â | Â | 0.000* | 0.2 | 0.1- 0.5 | 0.001* |
   Yes | 54 | 78 |  |  |  |  |
   No | 24 | 26 |  |  |  |  |
Chemotherapy | Â | Â | 0.078 | NS | ||
   Yes | 72 | 34 |  |  |  |  |
   No | 61 | 62 |  |  |  |  |
Radiotherapy & | Â | Â | 0.04* | 0.3 | 0.1- 0.9 | 0.026* |
   Yes | 59 | 63 |  |  |  |  |
   No | 74 | 32 |  |  |  |  |